Difference between revisions of "WSI21-171-Case-4"
From MGH Learn Pathology
(Edited automatically from page WSI21-171.) |
(Updating subject, access, and performer) |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | {{ | + | {{ServiceRequestCase |
− | | | + | |identifier=WSI21-171-Case-4 |
− | | | + | |intent=order |
− | | | + | |category=409073007 |
− | | | + | |priority=routine |
− | | | + | |orderDetail=case |
− | | | + | |locationCode=learn |
− | | | + | |basedOn=WSI21-171 |
+ | |code=cme | ||
+ | |requisition=CCSP 2021 | ||
+ | |supportingInfo=Cholestatic hepatitis with bile infarcts, consistent with biliary obstruction. | ||
+ | |reasonCode=62 year old man with history of severe COVID19, presents with elevated LFTs 3 months after initial infection. ALT 334. AST 217. ALP > 2200. | ||
+ | |subject=MGH | ||
+ | |performer=AZ375 | ||
+ | |sequence=4 | ||
+ | |access=public | ||
}} | }} | ||
− | {{ | + | {{Media |
− | + | |basedOn=WSI21-171-Case-4 | |
− | | | + | |type=image |
− | | | + | |view=show |
− | | | + | |partOf=WSI21-171 |
− | | | + | |frames=1 |
+ | |reasonCode=H&E | ||
+ | |identifier=WSI21-171-Case-4_1 | ||
+ | |modality=mrxs | ||
}} | }} | ||
− | {{ | + | {{Media |
− | | | + | |basedOn=WSI21-171-Case-4 |
− | | | + | |type=image |
− | | | + | |view=show |
− | | | + | |partOf=WSI21-171 |
+ | |frames=2 | ||
+ | |reasonCode=Trichrome | ||
+ | |identifier=WSI21-171-Case-4_2 | ||
+ | |modality=mrxs | ||
}} | }} |
Latest revision as of 15:24, June 21, 2022